InvestorsHub Logo

DEVJ

06/01/18 1:52 PM

#388 RE: ronpopeil #387

I believe any deal with some other company would launch Emis to a whole different level. And of course having Eligen B12 as additional validation doesn't hurt; although its impact right now is minor.